NCT06511583

Brief Summary

Non-Profit Prospective Observational Pilot Study The study will have an overall duration of 3 years, with patient enrollment starting after ethical committee approval. In this study, all patients with a diagnosis of aspiration pneumonia who require aspiration of secretions or ingesta in the Emergency Department will be considered. A registry will be created with the patients\' data, noting the type of procedure performed: laryngotracheal aspiration with a probe or with fibrobronchoscopy. This observational registry pilot study aims to evaluate the utility and adverse events related to the use of aspiration via videobronchoscopy performed in the Emergency Department and to compare the clinical outcomes of patients undergoing bronchoscopy with those treated only with blind laryngotracheal aspiration using a probe.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
10mo left

Started Feb 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Feb 2024Mar 2027

Study Start

First participant enrolled

February 5, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 10, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 22, 2024

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2027

Expected
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2027

Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

3 years

First QC Date

July 10, 2024

Last Update Submit

July 15, 2024

Conditions

Keywords

Aspiration pneumoniaBronchoscopytoiletteinterventional pulmunologyrespiratory failurepneumoniabacterial pneumonia

Outcome Measures

Primary Outcomes (2)

  • Length of hospital stay in days

    Length of hospital stay in days

    up to 3 months

  • Mortality rate within 30 days from the time of admission to the Emergency Department

    Mortality rate within 30 days from the time of admission to the Emergency Department

    30 days from admission to the ed

Secondary Outcomes (4)

  • Respiratory parameters before and after the procedure

    on the admission and 30 minutes after the procedure

  • Rate of patient treated with Non invase ventilation and with orotracheal intubation

    on the admission and 30 minutes after the procedure

  • Rate of admission in Intensive care unit and High dependency unit

    immediately after the procedure

  • Procedure-related complications

    perioperatively/periprocedurally

Study Arms (2)

Laryngotracheal Aspiration Procedure Using a Probe in the Emergency Department

Patients with aspiration pneumonia. For laryngotracheal aspiration using a blind probe, the patient will be positioned in a seated or semi-seated position; if this is not possible, the aspiration will be performed in a supine position. A soft, sterile catheter connected to the suction apparatus will be inserted into one nostril while keeping the patient's head tilted back. When the tip of the catheter reaches the back of the pharynx, the patient will need to breathe to facilitate the insertion and allow the catheter to advance into the larynx and trachea. At this point, using negative suction pressure for a maximum of 3-5 seconds, the secretions will be aspirated. The aspiration will be repeated multiple times in cycles of 3-5 seconds.

Procedure: Laryngotracheal Aspiration Procedure Using a Probe in the Emergency Department

Aspiration Using Fibrobronchoscopy in the Emergency Department

Patients with aspiration pneumonia. The bronchoscope will be gently inserted through the patient's nostril or mouth, advancing carefully through the pharynx and larynx into the trachea and bronchi. The physician will visually inspect the airways through the bronchoscope. Using the bronchoscope's suction channel, secretions will be aspirated from the trachea and bronchi. Suctioning will be performed intermittently to avoid hypoxia, with each suctioning cycle lasting no more than 3-5 seconds. The procedure may be repeated as necessary to ensure thorough aspiration of secretions.

Procedure: Aspiration Procedure Using Fibrobronchoscopy in the Emergency Department

Interventions

For laryngotracheal aspiration using a blind probe, the patient will be positioned in a seated or semi-seated position; if this is not possible, the aspiration will be performed in a supine position. A soft, sterile catheter connected to the suction apparatus will be inserted into one nostril while keeping the patient\'s head tilted back. When the tip of the catheter reaches the back of the pharynx, the patient will need to breathe to facilitate the insertion and allow the catheter to advance into the larynx and trachea. At this point, using negative suction pressure for a maximum of 3-5 seconds, the secretions will be aspirated. The aspiration will be repeated multiple times in cycles of 3-5 seconds.

Laryngotracheal Aspiration Procedure Using a Probe in the Emergency Department

Equipment Setup: A sterile bronchoscope will be connected to the suction apparatus. Procedure: The bronchoscope will be gently inserted through the patient\'s nostril or mouth, advancing carefully through the pharynx and larynx into the trachea and bronchi. The physician will visually inspect the airways through the bronchoscope. Using the bronchoscope's suction channel, secretions will be aspirated from the trachea and bronchi. Suctioning will be performed intermittently to avoid hypoxia, with each suctioning cycle lasting no more than 3-5 seconds. The procedure may be repeated as necessary to ensure thorough aspiration of secretions.

Aspiration Using Fibrobronchoscopy in the Emergency Department

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will be conducted on patients with a diagnosis of aspiration pneumonia who, based on the judgment of the attending physician, require aspiration of secretions or ingesta in the emergency department using a probe and/or a fiberscope. Enrollment in the study will be determined by the Emergency Department physician in charge of the patient. Estimated number of patients to be enrolled: 100.

You may qualify if:

  • All adult patients who access the Emergency Department with a diagnosis of aspiration pneumonia and for whom the referring physician determines the need for aspiration of secretions or ingesta. Patients must have at least one of the following criteria
  • Radiological evidence of pneumonia (Chest X-ray/CT scan/Chest ultrasound)
  • Clinical diagnosis of aspiration pneumonia
  • Presence of secretions in the upper airways
  • Respiratory distress in a dysphagic patient
  • Need for oxygen therapy or need to increase FiO2 in patients already on home oxygen therapy

You may not qualify if:

  • Lack of consent
  • Age \< 18 years
  • Pregnancy
  • Hemorrhagic diathesis
  • Malignant cardiac arrhythmias (VT, AV block excluding first-degree AV block)
  • Severe airway obstruction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AOU Careggi

Florence, Tuscany/Italy, 50122, Italy

RECRUITING

MeSH Terms

Conditions

Pneumonia, AspirationRespiratory InsufficiencyPneumoniaPneumonia, Bacterial

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract DiseasesRespiration DisordersBacterial InfectionsBacterial Infections and Mycoses

Study Officials

  • Lorenzo Pelagatti, dr

    University of Florence

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 10, 2024

First Posted

July 22, 2024

Study Start

February 5, 2024

Primary Completion (Estimated)

February 5, 2027

Study Completion (Estimated)

March 5, 2027

Last Updated

July 22, 2024

Record last verified: 2024-07

Locations